EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $855,996 | -36.8% | 54,280 | -22.1% | 0.00% | -20.0% |
| Q2 2023 | $1,354,657 | -36.0% | 69,684 | -6.6% | 0.01% | -44.4% |
| Q1 2023 | $2,116,828 | +71.3% | 74,615 | +76.5% | 0.01% | +50.0% |
| Q4 2022 | $1,235,727 | -19.1% | 42,276 | +23.0% | 0.01% | -25.0% |
| Q2 2022 | $1,527,000 | -28.9% | 34,358 | -20.8% | 0.01% | 0.0% |
| Q1 2022 | $2,148,000 | +8.4% | 43,394 | +11.5% | 0.01% | +14.3% |
| Q4 2021 | $1,982,000 | -8.7% | 38,918 | -0.1% | 0.01% | -30.0% |
| Q3 2021 | $2,172,000 | +18.8% | 38,939 | -8.8% | 0.01% | +25.0% |
| Q2 2021 | $1,828,000 | +148.0% | 42,709 | +141.9% | 0.01% | +166.7% |
| Q1 2021 | $737,000 | -20.0% | 17,659 | -10.7% | 0.00% | -25.0% |
| Q4 2020 | $921,000 | -43.2% | 19,774 | -48.2% | 0.00% | -42.9% |
| Q3 2020 | $1,621,000 | -26.2% | 38,149 | -16.7% | 0.01% | -36.4% |
| Q2 2020 | $2,197,000 | +48.7% | 45,786 | +42.6% | 0.01% | +22.2% |
| Q1 2020 | $1,477,000 | +16.0% | 32,105 | +51.5% | 0.01% | +50.0% |
| Q4 2019 | $1,273,000 | +6.2% | 21,195 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $1,199,000 | +46.8% | 21,195 | +44.5% | 0.01% | +50.0% |
| Q2 2019 | $817,000 | +10.4% | 14,665 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $740,000 | +25.2% | 14,665 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $591,000 | -32.1% | 14,665 | +16.9% | 0.00% | -20.0% |
| Q3 2018 | $870,000 | – | 12,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |